New data documented dramatic shifts in prescribing for both type 2 diabetes (T2D) and weight loss, particularly with the uptake of tirzepatide (Lilly) and declines in the use of older agents.

YKL-40 is an inflammatory biomarker linked to tumour progression in various cancers, and its levels are consistently elevated in patients with T2D, a condition linked to increased risks for ...

Patients with type 2 diabetes and comorbid lung function impairment had higher risks for cardiovascular disease and mortality. Individuals with type 2 diabetes (T2D) and comorbid lung function ...

Researchers conducted a large-scale epidemiological study to explore the potential health benefits of high muscle strength in preventing type 2 diabetes (T2D) across varying levels of genetic risk.

Smartwatches may help control diabetes through exercise Date: March 27, 2025 Source: Lancaster University Summary: Wearable mobile health technology could help people with Type 2 Diabetes (T2D) to ...

The phase III ACHIEVE-1 study, the first of seven late-stage studies, is evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes (T2D) and inadequate ...

(Annals of Internal Medicine) Eating certain combinations of food additives may increase the risk for T2D, according to results of a study published in PLOS Medicine. Sen. John Fetterman (D-Pa.) ...